| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910459646803321 |
|
|
Titolo |
Metabolic risk for cardiovascular disease [[electronic resource] /] / edited by Robert H. Eckel |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Dallas, TX, : American Heart Association |
|
Chichester, West Sussex, UK, : Wiley-Blackwell, 2010 |
|
|
|
|
|
|
|
|
|
ISBN |
|
1-4443-4778-0 |
1-282-77715-7 |
9786612777158 |
1-4443-2479-9 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (261 p.) |
|
|
|
|
|
|
Collana |
|
|
|
|
|
|
Altri autori (Persone) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Cardiovascular system - Diseases - Risk factors |
Metabolic syndrome |
Obesity - Complications |
Lipids - Metabolism - Disorders - Complications |
Diabetes - Complications |
Electronic books. |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Metabolic Riskfor CardiovascularDisease; Contents; Contributors; Foreword; 1 Insulin action and beta-cell function: role in metabolic regulation; 2 Lipid and lipoprotein metabolism, and risk for cardiovascular disease; 3 Tobacco and risk for cardiovascular disease; 4 Nutrition and risk for cardiovascular disease; 5 Physical activity and cardiovascular health; 6 The obesity epidemic and cardiovascular risk; 7 Insulin resistance, the metabolic syndrome, and cardiovascular risk; 8 Diabetes mellitus and cardiovascular risk; 9 Lipid management and cardiovascular risk reduction |
10 Obesity management and cardiovascular risk reduction11 Diabetes management and cardiovascular risk reduction; 12 A healthy lifestyle and cardiovascular risk reduction; Index; Author Disclosure Table |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
The relationship of metabolic diseases to cardiovascular disease (CVD) |
|
|
|
|
|
|
|
|
|
|
is reaching epidemic proportions. This relates mostly to the increasing prevalence of obesity, the metabolic syndrome and type 2 diabetes. This book outlines and addresses the metabolic factors and related diseases that contribute to CVD, including brief introductions to metabolic pathways including lipid and lipoprotein metabolism, macronutrient fuel partitioning, insulin action and body weight regulation. Mechanisms that relate to becoming obese, maintenance of the obese state, the dyslipidemias, and glucose intolerance |
|
|
|
|
|
| |